# Penn Pharmaceutical Services Limited - Inspection Records

Source: https://www.keypedia.com/companies/penn-pharmaceutical-services-limited/0568bf3c-6deb-4f8f-9174-a7ff34c80343

> Inspection records and compliance data for Penn Pharmaceutical Services Limited in Tredegar, None. Access full analysis and detailed observations.

---

## Details

- Name: Penn Pharmaceutical Services Limited
- FEI Number: 1000370240
- City: Tredegar
- State: None
- Country Name: United Kingdom
- Address Line 1: Unit 23-24, Tafarnaubach Industrial Estate
- Zip Code: None

## Related Documents

- [FDA Inspection 1181809 - Penn Pharmaceutical Services Limited - 2022-04-01](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/3e33f75c-d34c-41a0-b120-71f675da3054) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 1, 2022
- [FDA Inspection 1081935 - Penn Pharmaceutical Services Limited - 2019-02-01](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/346d2c68-a717-4d48-9628-3694c53a6dbb) — classification: No Action Indicated (NAI), source: FDA, date: February 1, 2019
- [FDA Inspection 1004548 - Penn Pharmaceutical Services Limited - 2017-03-01](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/839a34f1-8859-4f16-996f-8f3530ab0d4d) — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2017
- [FDA Inspection 1004548 - Penn Pharmaceutical Services Limited - 2017-03-01](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/87bcc6b6-03c3-4dd7-a881-0f23fcfd54c1) — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2017
- [FDA Inspection 1004548 - Penn Pharmaceutical Services Limited - 2017-03-01](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/35d515fc-b33d-4413-b924-842daeb28cf1) — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2017
- [FDA Inspection 1063598 - Penn Pharmaceutical Services Limited - 2017-01-26](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/1529d02a-d1ba-4523-bd8e-43b485befa2e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 26, 2017
- [FDA Inspection 979658 - Penn Pharmaceutical Services Limited - 2016-07-08](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/f22da230-3242-4280-8173-4334b0f4e6c4) — classification: No Action Indicated (NAI), source: FDA, date: July 8, 2016
- [FDA Inspection 979658 - Penn Pharmaceutical Services Limited - 2016-07-08](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/c6a80434-799b-4c5c-bee0-62e328402029) — classification: No Action Indicated (NAI), source: FDA, date: July 8, 2016
- [FDA Inspection 822276 - Penn Pharmaceutical Services Limited - 2013-02-07](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/5a350194-1cc5-4672-9a58-9723777313e9) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2013
- [FDA Inspection 822276 - Penn Pharmaceutical Services Limited - 2013-02-07](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/56d9c8ff-c300-48db-9468-d0365cc23d38) — classification: Official Action Indicated (OAI), source: FDA, date: February 7, 2013

## Related Companies

- [Combe Laboratories, Inc.](https://www.keypedia.com/companies/combe-laboratories-inc/165d44db-fdc0-4975-af22-35ec39c2735d)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/bc21b600-e8f7-4570-9285-d3c41399fd82)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/03c10541-23fe-4547-ae02-c47669f35343)
- [Delpharm Huningue S.A.S.](https://www.keypedia.com/companies/delpharm-huningue-sas/abe67002-072d-48fc-8ace-21b8021482f7)
- [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/afdfe2db-9213-4d8d-84c3-4627195bb4c7)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [S.s.s. Company (international)](https://www.keypedia.com/companies/sss-company-international/f322f704-186a-434c-83d2-9468fed1ae6e)
- [NORTON (WATERFORD) LIMITED](https://www.keypedia.com/companies/norton-waterford-limited/776bb20e-6234-4ca9-94ef-034d468a479a)